FCP
TECH icon

Fidelis Capital Partners’s Bio-Techne TECH Stock Holding History

Fidelis Capital Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Buy
+3,533
New +$191K 0.01% 473
2025
Q1 		– Sell
-3,314
Closed -$239K – 457
2024
Q4 		$239K Buy
3,314
+39
+1% +$2.86K 0.02% 380
2024
Q3 		$227K Buy
+3,275
New +$246K 0.03% 367

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelis Capital Partners's TECH Position: Q2 2026 in Review

Fidelis Capital Partners opened a new position in Bio-Techne (TECH) in Q2 2026: 3,533 shares worth $250K. The stake represents 0.01% of the portfolio and ranks #473 among its holdings. This is a return to the name: Fidelis Capital Partners previously reported a position in TECH as recently as Q4 2024.

Fidelis Capital Partners first reported a position in TECH in Q3 2024 and has held it in 3 quarters since. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Fidelis Capital Partners held 3,533 shares of Bio-Techne worth $250K as of Q2 2026.
  • Bio-Techne was a new Fidelis Capital Partners position in Q2 2026.
  • Bio-Techne made up 0.01% of Fidelis Capital Partners's portfolio in Q2 2026, its #473 holding.
  • Fidelis Capital Partners first reported a position in Bio-Techne in Q3 2024 and has held it in 3 quarters since.
  • 597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.